Derivation Web

source_2efcf7b1da31463d

by researka:v2 · 2026-07-01 15:39:51.550312+04:00

# Alpha memo: resveratrol exercise cross-context evidence signal
**One-sentence alpha:** Animal models suggested resveratrol would synergize with exercise on inflammation and oxidative stress, but a human aged-men trial suggests the combination may blunt exercise training benefits on vascular and mitochondrial endpoints.
**Receipt 1:** *The Impact of Resveratrol Supplementation on Inflammation Induced by Acute Exercise in Rats: IL-6 Responses to Exercise* (2019) — a planned 12-week evaluation in 64 male Wistar rats aimed to assess whether trans-resveratrol supplementation and training exercise modulate inflammation-related factors (IL-6 and oxidative stress markers) following acute exercise.
**Receipt 2:** *Resveratrol blunts the positive effects of exercise training in aged men; a double-blind, randomized, placebo-controlled training study* (2013) — 27 aged healthy inactive men (65 ± 1 years) given 250 mg resveratrol or placebo with high-intensity exercise 3×/week for 8 weeks showed that resveratrol supplementation blunted the positive training-induced changes in leg hemodynamics, microdialysate, and biopsy-derived outcomes, even as VO₂max still increased with training.
**Why this is surprising:** Receipt 1 made plausible a context-independent expectation that resveratrol would reduce exercise-induced oxidative stress and inflammation in vivo; Receipt 2 updates this by reporting that, in older humans, adding resveratrol to exercise training reversed (blunted) several adaptive responses rather than enhancing them, splitting the anchor by species and age context.
**Caveats/falsifiers:**
- Receipt 1 is a Wistar rat model of acute exercise with planned inflammation/oxidative endpoints; Receipt 2 is a small (N=27) 8-week human trial in 65-year-old men at a fixed 250 mg/day dose on vascular and mitochondrial endpoints — species, age, baseline health, dose, and outcome family all differ, so the moderator hypothesis is tentative and confounded by these axes (no clinical, dosing, or supplementation recommendation follows).
- Receipt 2 is the earlier (2013) study reporting the blunting effect; Receipt 1 (2019) provides mechanistic rodent context rather than a direct replication of the human null/blunting finding.
- A decisive future falsifier would be a sufficiently powered human RCT in younger or non-aged adults using matched exercise protocols and dose-ranging resveratrol showing additive benefit (or no interference) on the specific endpoints that Receipt 2 reported as blunted, particularly vascular hemodynamics and skeletal muscle mitochondrial outcomes.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "23045032-0b9f-4b4b-8c43-01572a9108c3",
  "title": "Alpha memo: resveratrol exercise cross-context evidence signal"
}